Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 13118 [2017-04622]

Download as PDF 13118 Federal Register / Vol. 82, No. 45 / Thursday, March 9, 2017 / Notices related to this announcement is identified in Unit I. under SUPPLEMENTARY INFORMATION. FOR FURTHER INFORMATION CONTACT: For technical information contact: John Schaeffer, Chemical Control Division (7405M), Office of Pollution Prevention and Toxics, Environmental Protection Agency, 1200 Pennsylvania Ave. NW., Washington, DC 20460–0001; telephone number: (202) 564–8173; email address: schaeffer.john@epa.gov. For general information contact: The TSCA-Hotline, ABVI-Goodwill, 422 South Clinton Ave., Rochester, NY 14620; telephone number: (202) 554– 1404; email address: TSCA-Hotline@ epa.gov. SUPPLEMENTARY INFORMATION: I. Chemical Substances and/or Mixtures Information received about the following chemical substances and/or mixtures is provided in Unit IV.: A. Acetaldehyde (CASRN 75–07–0). B. D-erythro-hex-2-enonic acid, gamma.-lactone, monosodium salt. (CASRN 6381–77–7). II. Authority Section 4(d) of TSCA (15 U.S.C. 2603(d)) requires EPA to publish a notice in the Federal Register reporting the receipt of information submitted pursuant to a rule, order, or consent agreement promulgated under TSCA section 4 (15 U.S.C. 2603). asabaliauskas on DSK3SPTVN1PROD with NOTICES III. Docket Information A docket, identified by the docket identification (ID) number EPA–HQ– OPPT–2013–0677, has been established for this Federal Register document, which announces the receipt of the information. Upon EPA’s completion of its quality assurance review, the information received will be added to the docket identified in Unit IV., which represents the docket used for the TSCA section 4 rule, order, and/or consent agreement. In addition, once completed, EPA reviews of the information received will be added to the same docket. Use the docket ID number provided in Unit IV. to access the information received and any available EPA review. EPA’s dockets are available electronically at http:// www.regulations.gov or in person at the Office of Pollution Prevention and Toxics Docket (OPPT Docket), Environmental Protection Agency Docket Center (EPA/DC), West William Jefferson Clinton Bldg., Rm. 3334, 1301 Constitution Ave. NW., Washington, DC. The Public Reading Room is open from 8:30 a.m. to 4:30 p.m., Monday through Friday, excluding legal VerDate Sep<11>2014 17:43 Mar 08, 2017 Jkt 241001 holidays. The telephone number for the Public Reading Room is (202) 566–1744, and the telephone number for the OPPT Docket is (202) 566–0280. Please review the visitor instructions and additional information about the docket available at http://www.epa.gov/dockets. IV. Information Received As specified by TSCA section 4(d), this unit identifies the information received by EPA. A. Acetaldehyde (CASRN 75–07–0). 1. Chemical Uses: Acetaldehyde is used as an intermediate in the manufacture of many products, including pyridines, acetate esters, pentaerythritol, peracetic acid, 1,3butylene glycol (1,3-Butanediol), and acetic acid. 2. Applicable Rule, Order, or Consent Agreement: Chemical testing requirements for second group of high production volume chemicals (HPV2), 40 CFR 799.5087. 3. Applicable docket ID number: The information received will be added to docket ID number EPA–HQ–OPPT– 2007–0531. 4. Information Received: EPA received the following information: Request for exemption from testing requirements. B. D-erythro-hex-2-enonic acid, gamma.-lactone, monosodium salt. (CASRN 6381–77–7). 1. Chemical Uses: D-erythro-hex-2enonic acid, gamma.-lactone, monosodium salt is used as an antioxidant in food applications for which the vitamin activity of ascorbic acid (Vitamin C) is not required. Specifically, the compound is most frequently used to develop and retain the coloring and taste in meat products. It is also used for seafood products, fruit, and vegetable preservation, in beverages, and as a developing agent in photographic applications. 2. Applicable Rule, Order, or Consent Agreement: Chemical testing requirements for second group of high production volume chemicals (HPV2), 40 CFR 799.5087. 3. Applicable docket ID number: The information received will be added to docket ID number EPA–HQ–OPPT– 2007–0531. 4. Information Received: EPA received the following information: Request for exemption from testing requirements. Authority: 15 U.S.C. 2601 et seq. PO 00000 Frm 00030 Fmt 4703 Sfmt 9990 Dated: February 15, 2017. Maria J. Doa, Director, Chemical Control Division, Office of Pollution Prevention and Toxics. [FR Doc. 2017–04697 Filed 3–8–17; 8:45 am] BILLING CODE 6560–50–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces a meeting for the initial review of applications in response to Funding Opportunity Announcement (FOA), RFA–CE–17–001, Research Using Linked Data to Understand Motor Vehicle Injury Among Older Adults. Time and Date: 9:00 a.m.–5:00 p.m., EDT, April 11, 2017 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Research Using Linked Data to Understand Motor Vehicle Injury Among Older Adults’’, FOA RFA–CE– 17–001. Contact Person for More Information: Kimberly Leeks, Ph.D., M.P.H., Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F78, Atlanta, Georgia 30341–3717, Telephone: (770) 488–5964. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2017–04622 Filed 3–8–17; 8:45 am] BILLING CODE 4163–18–P E:\FR\FM\09MRN1.SGM 09MRN1

Agencies

[Federal Register Volume 82, Number 45 (Thursday, March 9, 2017)]
[Notices]
[Page 13118]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-04622]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces a meeting for the initial review of 
applications in response to Funding Opportunity Announcement (FOA), 
RFA-CE-17-001, Research Using Linked Data to Understand Motor Vehicle 
Injury Among Older Adults.
    Time and Date: 9:00 a.m.-5:00 p.m., EDT, April 11, 2017 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and 
the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters for Discussion: The meeting will include the initial 
review, discussion, and evaluation of applications received in response 
to ``Research Using Linked Data to Understand Motor Vehicle Injury 
Among Older Adults'', FOA RFA-CE-17-001.
    Contact Person for More Information: Kimberly Leeks, Ph.D., M.P.H., 
Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F78, 
Atlanta, Georgia 30341-3717, Telephone: (770) 488-5964.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2017-04622 Filed 3-8-17; 8:45 am]
 BILLING CODE 4163-18-P